2Lou XE-Xu N, Yao HP, ^ al. Bicyclol attenuates pro-inflam-matory cytokine and chemokine productions inCpG~DNA'stim-ulated 11)2 hepatocytes by inhibiting p65-NF-jcB and p38-MAPK activation[J]. Pharmazie,2010,65?3) :206-212.
3Yu YN, Chen H, Li Y. Effect of bicyclol on cisplatin-inducedhepatotoxicity in the hcpatocarcinoma 22 tumour-bearing micc[J]. Basic Clin Pharmacol Toxicol,2009,104: 300-305.
7Gao X, Fan JG. Diagnosis and management of non-alcoholic fattyliver disease and related metabolic disorders: consensus statementfrom the Study Group of Liver and Metabolism?Chinese Society ofEndocrinology [J ]. J Diabetes,2013,5(4) :56-58.
8Sun H,Liu G T. Chemopreventive effect of bicyclol on malig-nant transformation of WB~F: 144 rat liver epithelial cells andits effect on related signal transduction in vitro [J]. CancerLett,2006,236(2) :239-249.
